In the US, Amoxapine (amoxapine systemic) is a member of the drug class tricyclic antidepressants and is used to treat Depression.
US matches:
- Amoxapine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06AA17
CAS registry number (Chemical Abstracts Service)
0014028-44-5
Chemical Formula
C17-H16-Cl-N3-O
Molecular Weight
313
Therapeutic Category
Antidepressant, tricyclic
Chemical Name
Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-
Foreign Names
- Amoxapinum (Latin)
- Amoxapin (German)
- Amoxapine (French)
- Amoxapina (Spanish)
Generic Names
- Amoxapine (OS: USAN, DCF, BAN)
- CL 67772 (IS: Lederle)
- Amoxapine (PH: USP 32, JP XV)
Brand Names
- Amoxan
Wyeth KK, Japan - Amoxapine
Watson, United States - Défanyl
Eisai, France - Demolox
Wyeth, India
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment